- Home
- SYK
as 11-25-2025 9:37am EST
Stryker designs, manufactures, and markets an array of medical equipment, instruments, consumable supplies, and implantable devices. The product portfolio includes hip and knee replacements, extremities, endoscopy systems, operating room equipment, embolic coils, hospital beds and gurneys, and orthopedic robotics. Stryker remains one of the three largest competitors in reconstructive orthopedic implants and holds the leadership position in operating room equipment. Roughly one-fourth of Stryker's total revenue currently comes from outside the United States.
| Founded: | 1941 | Country: | United States |
| Employees: | N/A | City: | PORTAGE |
| Market Cap: | 141.2B | IPO Year: | N/A |
| Target Price: | $435.33 | AVG Volume (30 days): | 1.8M |
| Analyst Decision: | Buy | Number of Analysts: | 16 |
| Dividend Yield: | Dividend Payout Frequency: | Quarterly | |
| EPS: | 7.61 | EPS Growth: | -18.39 |
| 52 Week Low/High: | $329.16 - $406.19 | Next Earning Date: | 10-30-2025 |
| Revenue: | $24,381,000,000 | Revenue Growth: | 10.95% |
| Revenue Growth (this year): | 11.94% | Revenue Growth (next year): | 8.57% |
Stock Insider Trading Activity of Stryker Corporation (SYK)
| Name | Ticker | Relationship | Date | Transaction | AVG Cost Per Share | Shares | Total Value | Securities Owned After Transaction(s) | SEC Form 4 |
|---|---|---|---|---|---|---|---|---|---|
| Wells Preston Wendell | SYK | VP, Chief Financial Officer | Nov 20 '25 | Sell | $365.88 | 165 | $60,370.20 | 6,694 | |
| Berry William E Jr | SYK | VP, Chief Accounting Officer | Nov 14 '25 | Sell | $365.49 | 1,953 | $713,801.97 | 2,833 | |
| STRYKER RONDA E | SYK | Director | Nov 6 '25 | Sell | $353.13 | 276,173 | $97,565,693.64 | 2,977,885 | |
| STRYKER RONDA E | SYK | Director | Nov 5 '25 | Sell | $356.95 | 243,827 | $87,040,447.25 | 2,977,885 |
Latest Stryker Corporation News
SYK Breaking Stock News: Dive into SYK Ticker-Specific Updates for Smart Investing
MedTech Dive
a day ago
Okami raises $45M to commercialize vascular embolization devices
GlobeNewswire
a day ago
Medical Precision Parts Research Report 2025: A $22.42 Bn by 2030, Driven by Automation-Driven Demand for Precision Fluidic Components, Advanced Surface Engineering for Biocompatibility & Anti-Fouling
StockStory
4 days ago
Medical Devices & Supplies - Diversified Stocks Q3 Results: Benchmarking Stryker (NYSE:SYK)
GlobeNewswire
6 days ago
Knee Replacement Surgery Market Analysis Report 2025-2035: Stryker, Zimmer Biomet, B. Braun, and DePuy Synthes Lead Innovations by Continually Innovating and Improving Patient Outcomes
Argus Research
7 days ago
Analyst Report: Stryker Corp.
Argus Research
7 days ago
Market Digest: AEP, CMCSA, SYK, KDP, BUD, UBER, DUOL
MT Newswires
11 days ago
Truist Raises Price Target on Stryker to $400 From $392, Keeps Hold Rating
MT Newswires
11 days ago
Wells Fargo Adjusts Price Target on Stryker to $456 From $452, Maintains Overweight Rating
Compare SYK vs Leading Stocks
Share on Social Networks:
Disclaimer
The information presented on this page, "SYK Stryker Corporation - Stocks Price | History | Analysis", including historical data, forecasts, news, insider information, and predictions, is provided for educational purposes only. It should not be considered as financial advice or a recommendation to buy or sell any securities. Decisions regarding investments should be made only after careful consideration and consultation with a qualified financial advisor. We do not endorse or guarantee the accuracy or reliability of the information provided, and we disclaim any liability for financial losses incurred as a result of decisions made based on the information presented.